Cooley advises Zymergen on patent matters surrounding $400 million landmark agtech deal

Cooley advised Zymergen on patent prosecution and IP diligence matters surrounding its $400 million Series C funding which closed in December 2018 and was led by returning investor SoftBank Vision Fund. The deal is the largest round of funding for a US-based startup operating upstream in the food and agriculture supply chain. Cooley lawyers Erich Veitenheimer and Chris Holly headed the team advising Zymergen.

Zymergen is the world’s first molecular manufacturing technology company, developing molecules used in industries including agriculture, chemicals, materials, pharmaceuticals, electronics and more.

Cooley’s patent team advises Zymergen on all aspects of IP matters, including the company’s foundational high-throughput genomic engineering platform.
Related Contacts
Erich Veitenheimer Partner, Washington, DC
Chris Holly Associate, Washington, DC
Marcelo Pomeranz Associate, Washington, DC
Anne Fleckenstein Associate, Washington, DC
Yi Wang Associate, Washington, DC
Erin Foley Associate, Washington, DC
Xiaoxiao Xue Associate, Washington, DC
James Whittle Associate, Washington, DC
Catherine Cowley Associate, London
Jeffrey Bolland Patent Agent, Washington, DC
Jong-Jin (JJ) Han Patent Agent, Washington, DC
Trupti Joshi Patent Agent, Washington, DC
Michael McEvoy Patent Agent, Washington, DC
Jordan Phelan Patent Agent, Washington, DC
Jeffery Wyzykowski Patent Agent, Washington, DC